Quarterly infographic: MRSA, MSSA and Gram-negative bacteraemia and CDI, data up to January to March 2026
Updated 9 July 2026
Applies to England
© Crown copyright 2026
This publication is licensed under the terms of the Open Government Licence v3.0 except where otherwise stated. To view this licence, visit or write to the Information Policy Team, The National Archives, Kew, London TW9 4DU, or email: psi@nationalarchives.gov.uk.
Where we have identified any third party copyright information you will need to obtain permission from the copyright holders concerned.
This publication is available at /government/statistics/mrsa-mssa-gram-negative-bacteraemia-and-cdi-quarterly-report/quarterly-infographic-mrsa-mssa-and-gram-negative-bacteraemia-and-cdi-data-up-to-january-to-march-2026
Gram-negative bacteraemias (Klebsiella spp.,P. aeruginosa and E. coli)
Pseudomonas aeruginosa (P. aeruginosa) bacteraemia
January to March 2025: 6.7 out of every 100,000 persons developed a P. aeruginosaÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
January to March 2026: 7.3 out of every 100,000 persons developed a P. aeruginosaÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
Klebsiella spp.Ìý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹
January to March 2025: 21.9 out of every 100,000 persons developed a Klebsiella spp.Ìý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
January to March 2026: 22.8 out of every 100,000 persons developed a Klebsiella spp.Ìý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
Escherichia coli (E. coli) bacteraemia
January to March 2025: 71.6 out of every 100,000 persons developed an E. coliÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
January to March 2026: 71.9 out of every 100,000 persons developed an E. coliÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
Staphylococcus aureus (S. aureus)ÌýMRSAÌý²¹²Ô»åÌýMSSAÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹ and Clostridioides difficile (C. difficile) infections
Meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia
January to March 2025: 1.8 out of every 100,000 persons developed an MRSAÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
January to March 2026: 2.1 out of every 100,000 persons developed an MRSAÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
Meticillin-susceptible Staphylococcus aureus (MSSA) bacteraemia
January to March 2025: 23.9 out of every 100,000 persons developed an MSSAÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
January to March 2026: 23.9 out of every 100,000 persons developed an MSSAÌý²ú²¹³¦³Ù±ð°ù²¹±ð³¾¾±²¹.
Clostridioides difficile (C. difficile) infection
January to March 2025: 29.2 out of every 100,000 persons developed a C. difficileÌý¾±²Ô´Ú±ð³¦³Ù¾±´Ç²Ô.
January to March 2026: 28.1 out of every 100,000 persons developed a C. difficileÌý¾±²Ô´Ú±ð³¦³Ù¾±´Ç²Ô.